SDC VS PROK Stock Comparison

Performance

SDC
10/100

SDC returned -32.98% in the last 12 months. Based on SPY's performance of -7.17%, its performance is below average giving it a score of 10 of 100.

PROK
10/100

PROK returned -86.03% in the last 12 months. Based on SPY's performance of -13.43%, its performance is below average giving it a score of 10 of 100.

Sentiment

SDC
70/100

SDC had a bullish sentiment score of 69.85% across Twitter and StockTwits over the last 12 months. It had an average of 139.63 posts, 16,373.01 comments, and 17,465.68 likes per day.

PROK

"Sentiment" not found for PROK

Technicals

SDC
82/100

SDC receives a 82 of 100 based on 14 indicators. 11 are bullish, 2 are bearish.

PROK
11/100

PROK receives a 10 of 100 based on 14 indicators. 1 are bullish, 12 are bearish.

Earnings

SDC
10/100

SDC has missed earnings 9 times in the last 20 quarters.

PROK
49/100

PROK has missed earnings 2 times in the last 20 quarters.

Profit

SDC
10/100

Out of the last 19 quarters, SDC has had 0 profitable quarters and has increased their profits year over year on 0 of them.

PROK
10/100

Out of the last 12 quarters, PROK has had 0 profitable quarters and has increased their profits year over year on 0 of them.

Volatility

SDC
50/100

SDC has had an average amount of volatility over the last 12 months giving it a score of 50 of 100.

PROK
38/100

PROK has had a lower than average amount of volatility over the last 12 months giving it a score of 38 of 100.

All score calculations are broken down here to help you make more informed investing decisions

SmileDirectClub, Inc. Class A Common Stock Summary

Nasdaq / SDC

Healthcare

Medical Instruments & Supplies

SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment with a network of approximately 250 licensed orthodontists and general dentists through its teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.

ProKidney Corp. Class A Ordinary Shares Summary

Nasdaq / PROK

Healthcare

Biotechnology

ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.

Power up your portfolio